Related Experiment Videos
Pediatric gastroesophageal reflux disease
1University of Virginia Health Sciences Center, Charlottesville.
Insights
Gastroesophageal reflux (GER) in infants is common and often resolves naturally. Identifying infants needing medical or surgical GER treatment requires further research due to limited pediatric drug approvals and trials.
Area of Science:
- Pediatric Gastroenterology
- Neonatal Clinical Studies
Background:
- Gastroesophageal reflux (GER) is a prevalent clinical issue in infants.
- GER often presents as a normal developmental phase that resolves with age.
Purpose of the Study:
- To highlight the difficulties in identifying infants who require medical or surgical intervention for GER.
- To emphasize the need for further research into the therapeutic management of infantile GER.
Main Methods:
- Review of existing clinical trials and therapeutic guidelines for infantile GER.
- Analysis of medication approvals for pediatric use in the United States.
Main Results:
- Few well-designed clinical trials exist for infantile GER therapies.
- Many adult GER medications lack pediatric approval, complicating treatment options.
- Surgical intervention is typically reserved for severe, medically unresponsive GER cases.
Conclusions:
- Further investigation is crucial for establishing evidence-based treatment protocols for infantile GER.
- Current therapeutic options for GER in infants are limited by drug approval status and trial data.
- Careful patient selection is essential for both medical and surgical GER management in infants.
Abstract:
Gastroesophageal reflux is a recognized clinical problem in infancy. To a great extent it represents a normal behavior that improves with maturation. The identification of appropriate candidates for medical and surgical therapy of GER during infancy is difficult and deserves further study. There are few well-conducted clinical trials of therapy for infantile GER that compare the usual drugs used for adults with GER. Moreover, medications currently licensed for adults are often not approved for pediatric use in the United States. Surgical therapy for GER should be reserved for infants with severe disease that does not respond to medical therapy.